XERS
Xeris Biopharma Holdings, Inc.
Nasdaq Pharmaceutical Preparations Large accelerated filer

Key Financials

Operating Income
$24.9M
↑ 174.0%
Gross Profit
$19.7M
N/A
Net Income
$554000
↑ 101.0%
Revenue
$291.8M
↑ 43.7%
EPS (Diluted)
$0.00
↑ 100.0%
Total Assets
$383.5M
↑ 18.7%
Total Liabilities
$369.8M
↑ 4.9%
Shareholders' Equity
$13.7M
↑ 146.2%

Recent SEC Filings

Form Type Filed Date Link
4 8/12/2026 View on SEC
144 8/12/2026 View on SEC
10-Q 8/6/2026 View on SEC
8-K 8/6/2026 View on SEC
4 8/4/2026 View on SEC
4 8/4/2026 View on SEC
SCHEDULE 13G 7/31/2026 View on SEC
8-K 7/17/2026 View on SEC
4 7/7/2026 View on SEC
144 7/7/2026 View on SEC

Company Information

Field Value
Ticker XERS
Company Name Xeris Biopharma Holdings, Inc.
CIK 1867096
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
Phone 844-445-5704